Last $5.14 USD
Change Today -0.01 / -0.19%
Volume 473.5K
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:24 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark R. Baker J.D.

Chief Executive Officer, Director and Member of Science & Strategy Committee, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 3 different organizations across 2 different industries.

See Board Relationships
59$1,303,053
As of Fiscal Year 2013

Background*

Mr. Mark R. Baker, J.D. has been the Chief Executive Officer of Progenics Pharmaceuticals, Inc. since March 2011 and served as its President from September 2009 to March 3, 2011. Mr. Baker served as a Secretary and General Counsel of Progenics Pharmaceuticals, Inc. since June 20, 2005 and served as its Executive Vice President-Corporate from 2008 to 2009. He served as Senior Vice President of Progenics Pharmaceuticals Inc., since June 20, 2005. He served as Chief Legal ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

Director
Director
1999-Present
Chairman of the Board, Member of Executive Committee and Member of Compensation Committee
1999-Present
Non-Executive Chairman of the Board, Chief Legal Officer of Contigroup and Senior Vice President of Contigroup
2009-Present
Chief Executive Officer, Director and Member of Science & Strategy Committee

Education*

BA
Columbia Business School
JD
School Of Law, Columbia University

Other Affiliations*

Annual Compensation*

Salary$535,613
Total Annual Compensation$535,613

Stock Options*

All Other Compensation$15,892
Exercisable Options690,763
Unexercisable Options285,278
Unexercisable Options Value$36,000
Total Value of Options$36,000
Total Number of Options1,025,000

Total Compensation*

Total Annual Cash Compensation$862,161
Total Short Term Compensation$535,613
Other Long Term Compensation$15,892
Total Calculated Compensation$1,303,053
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $5.14 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.